Study of levodopa response in Parkinson's disease: Observations on rates of motor progression

被引:11
|
作者
Ding, Catherine [1 ]
Ganesvaran, Ganga [1 ]
Alty, Jane E. [1 ]
Clissold, Benjamin G. [1 ]
McColl, Craig D. [1 ]
Reardon, Katrina A. [1 ]
Schiff, Mark [1 ]
Srikanth, Velandai [1 ,3 ,4 ]
Kempster, Peter A. [1 ,2 ]
机构
[1] Monash Med Ctr, Dept Neurosci, 246 Clayton Rd, Clayton, Vic 3168, Australia
[2] Monash Univ, Dept Med, Clayton, Vic, Australia
[3] Monash Univ, Dept Med, Sch Clin Sci, Stroke & Ageing Res Grp,Vasc Brain Aging Div, Melbourne, Vic 3004, Australia
[4] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia
关键词
Parkinson's disease; levodopa; dementia; natural history; SUBSTANTIA-NIGRA; DURATION;
D O I
10.1002/mds.26497
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionIt is important to understand how the rate of motor progression in PD relates to dopaminergic treatment. MethodsThe methods for this study comprised prospective defined off state measurements of the levodopa response at 3-year intervals over a mean 13.3-year period in 34 patients enrolled before treatment initiation. ResultsDespite worsening of on and off scores, the magnitude of the l-dopa short-duration response is maintained as the disease progresses. A linear mixed-effects regression analysis of off phase motor scores showed a yearly deterioration of 2.3% of the maximum disability score. Greater motor disability at the commencement of treatment was an independent predictor of faster progression. Demented patients had worse motor function than those without dementia (P = 0.02), and motor deficit appeared to accelerate toward the end of the disease course in patients who had died. ConclusionsThese observations should inform clinical trial design for drugs with possible neuroprotective properties. (c) 2016 International Parkinson and Movement Disorder Society
引用
收藏
页码:589 / 592
页数:4
相关论文
共 50 条
  • [1] Longitudinal study of the motor response to levodopa in Parkinson's disease
    Clissold, Benjamin G.
    McColl, Craig D.
    Reardon, Katrina R.
    Shiff, Mark
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2116 - 2121
  • [2] Longitudinal Study of the Levodopa Motor Response in Parkinson's Disease: Relationship Between Cognitive Decline and Motor Function
    Alty, Jane E.
    Clissold, Benjamin G.
    McColl, Craig D.
    Reardon, Katrina A.
    Shiff, Mark
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2009, 24 (16) : 2337 - 2343
  • [3] Motor complications, levodopa metabolism and progression of Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (07) : 847 - 855
  • [4] Differential progression of motor impairment in levodopa-treated Parkinson's disease
    Goetz, CG
    Stebbins, GT
    Blasucci, LM
    MOVEMENT DISORDERS, 2000, 15 (03) : 479 - 484
  • [5] Progression of motor symptoms in Parkinson's disease
    Xia, Ruiping
    Mao, Zhi-Hong
    NEUROSCIENCE BULLETIN, 2012, 28 (01) : 39 - 48
  • [6] Levodopa availability improves with progression of Parkinson’s disease
    Dirk Woitalla
    Oliver Goetze
    Jeong I. Kim
    Alice B. Nikodem
    Wolfgang E. Schmidt
    Horst Przuntek
    Thomas Müller
    Journal of Neurology, 2006, 253 : 1221 - 1226
  • [7] Levodopa availability improves with progression of Parkinson's disease
    Woitalla, Dirk
    Goetze, Oliver
    Kim, Jeong I.
    Nikodem, Alice B.
    Schmidt, Wolfgang E.
    Przuntek, Horst
    Mueller, Thomas
    JOURNAL OF NEUROLOGY, 2006, 253 (09) : 1221 - 1226
  • [8] Does levodopa slow or hasten the rate of progression of Parkinson’s disease?
    Stanley Fahn
    Journal of Neurology, 2005, 252 : iv37 - iv42
  • [9] Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn, S
    JOURNAL OF NEUROLOGY, 2005, 252 (Suppl 4) : 37 - 42
  • [10] Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease
    McColl, CD
    Reardon, KA
    Shiff, M
    Kempster, PA
    MOVEMENT DISORDERS, 2002, 17 (06) : 1227 - 1234